Biotech Values

[iwfal]

it seems to me now perhaps with the new "fda" , aka lower bars, the payers will be the gaters. which imo makes it harder for a petty speculator like myself to make a profit in "biotech values" lol.

FWIW, and as I've noted before, I agree. Partly because the insurance companies will be much more erratic in their 'approval' standards and everything, including their standards and the trials results, will be less transparent (and, yes, I think that will make medical advancement and current care substantially worse).

My only hope is that Gottleib isn't too extreme in this regard. Certainly he is *wildly* better than the Silicon Valley healthcare no-nothings.

PS What I find particularly bizarre in this case is that many of the most vocal about this issue have been people who pushed extremely hard for Eteplirsen approval (even after the FDA documents came out).